Bernard Le Foll

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (10)

Matthew Sloan

University of Toronto

CANADA

View details

Junchao Tong

Head, Preclinical Imaging

Centre for Addiction and Mental Health

CANADA

View details

Joshua Gowin

Assistant Professor

University of Colorado Boulder

UNITED STATES

View details

Stefan Kloiber

Max Planck Institute of Psychiatry

GERMANY

View details

Ahmed Hassan

assistant professor

University of Toronto

CANADA

View details

Rachel Fynvola Tyndale

CANADA

View details

Didier Jutras-Aswad

Université de Montréal

CANADA

View details

Wayne Hall

University of Queensland

AUSTRALIA

View details

M. Eugenia Socias

University of British Columbia Faculty of Medicine

CANADA

View details

Philip Tibbo

Professor, Dr. Paul Janssen Chair in Psychotic Disorders

Dalhousie University Faculty of Medicine

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bernard Le Foll

Research Interests

Explore related searches

Contact this professor

Articles (10)

Impact of Depressive Symptom Severity on Buprenorphine/Naloxone and Methadone Outcomes in People With Prescription-Type Opioid Use Disorder: Results From a Pragmatic Randomized Controlled Trial

Pharmacogenetics of Biochemically Verified Abstinence in an Opioid Agonist Therapy Randomized Clinical Trial of Methadone and Buprenorphine/Naloxone

Expectancies of the Effects of Cannabis Use in Individuals with Social Anxiety Disorder (SAD)

Neuromodulation for Cannabis Use: A Scoping Review

Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review

Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial

Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder—Preliminary Findings

Motivations for Cannabis Use in Individuals with Social Anxiety Disorder (SAD)

Efficacy of insula deep repetitive transcranial magnetic stimulation combined with varenicline for smoking cessation: A randomized, double-blind, sham controlled trial

Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study

Collaborators (10)

Matthew Sloan

Junchao Tong

Joshua Gowin

Stefan Kloiber

Ahmed Hassan

Rachel Fynvola Tyndale

Didier Jutras-Aswad

Wayne Hall

M. Eugenia Socias

Philip Tibbo

Make your next move.